TargetMol

C.I. 12170

Product Code:
 
TAR-T30648
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T30648-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T30648-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
C.I. 12170 is also known as Naphthylamine Bordeaux.
CAS:
2653-64-7
Molecular Weight:
298.345
Purity:
0.98
SMILES:
Oc1ccc2ccccc2c1N=Nc1cccc2ccccc12 |w:11.12|

References

Picard M, Tempere S, de Revel G, Marchand S. Piperitone Profiling in Fine Red Bordeaux Wines: Geographical Influences in the Bordeaux Region and Enantiomeric Distribution. J Agric Food Chem. 2016 Oct 12;64(40):7576-7584. Epub 2016 Sep 30. PubMed PMID: 27689433. Bertrand A, Kostine M, Barnetche T, Truchetet ME, Schaeverbeke T. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med. 2015 Sep 4;13:211. doi: 10.1186/s12916-015-0455-8. Review. PubMed PMID: 26337719; PubMed Central PMCID: PMC4559965. Glize B, Malvy D. Autochthonous strongyloidiasis, Bordeaux area, South-Western France. Travel Med Infect Dis. 2014 Jan-Feb;12(1):106-8. doi: 10.1016/j.tmaid.2012.12.002. Epub 2013 Feb 20. PubMed PMID: 23433632. Bastier PL, Lechot A, Bordenave L, Durand M, de Gabory L. Nasal irrigation: From empiricism to evidence-based medicine. A review. Eur Ann Otorhinolaryngol Head Neck Dis. 2015 Nov;132(5):281-5. doi: 10.1016/j.anorl.2015.08.001. Epub 2015 Sep 3. Review. PubMed PMID: 26344138.